NEW YORK (360Dx) – Three years after its founding and with a new name in tow, Nightingale Health is poised to move into the clinical market with technology that it said can provide information on 220 metabolic biomarkers for chronic diseases.
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
A trial upgrade to 360Dx Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.